| Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. | |
| | |
MedLine Citation:
|
PMID: 12377968 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To determine the prevalence of and contributing factors for chronic arm morbidity including lymphedema in breast cancer patients after treatment and to assess the impact of arm morbidity on quality of life (QOL). PATIENTS AND METHODS: A four-question screening questionnaire was developed and mailed to a random sample of 744 breast cancer patients treated curatively in two cancer centers from 1993 to 1997. Patients were without recurrence and at least 2 years from diagnosis. Respondents were classified as with or without arm-related symptoms on the basis of the survey. Stratified random samples from each group were then invited for a detailed assessment of their symptoms and signs, including the presence of lymphedema. Their QOL was assessed by the European Organization for Research and Treatment of Cancer QOL Questionnaire C-30 and by a detailed arm problem questionnaire that assessed various aspects of daily arm functioning. RESULTS: Approximately half of all screened patients were symptomatic and 12.5% of all assessed patients had lymphedema. Axillary dissection (AD) and axillary radiotherapy (RT) after dissection were statistically significantly related to the occurrence of arm symptoms (odds ratio for AD = 3.3, P <.001; odds ratio for RT = 3.1, P <.001). Symptomatic patients and patients with lymphedema both had impaired QOL compared with asymptomatic patients. CONCLUSION: Treatment for breast cancer is associated with considerable arm morbidity, which has a negative impact on QOL. Arm morbidity should be carefully monitored in future studies involving local treatment modalities for breast cancer. |
| | |
Authors:
|
Winkle Kwan; Jeremy Jackson; Lorna M Weir; Carol Dingee; Greg McGregor; Ivo A Olivotto |
Related Documents
:
|
14747038 - Use of nomograms to predict the risk of disease recurrence after definitive local thera... 15452868 - Development and validation of the unified multiple system atrophy rating scale (umsars). 19731348 - Quality of life in a prospective cohort of elderly women with and without cancer. 15936548 - A screening questionnaire for voice problems after treatment of early glottic cancer. 19701688 - Impact of a positive family history on diagnosis, management, and survival of breast ca... 18784658 - Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Volume: 20 ISSN: 0732-183X ISO Abbreviation: J. Clin. Oncol. Publication Date: 2002 Oct |
Date Detail:
|
Created Date: 2002-10-14 Completed Date: 2002-10-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8309333 Medline TA: J Clin Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 4242-8 Citation Subset: IM |
Affiliation:
|
Radiation Therapy Program, Surgical Oncology Program, and Breast Cancer Outcomes Unit of the British Columbia Cancer Agency-Fraser Valley Centre, Surrey, Canada. wkwan@bccancer.bc.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arm Breast Neoplasms / surgery* Chronic Disease Female Humans Lymphedema / epidemiology, etiology* Mastectomy / adverse effects* Morbidity Postoperative Complications / epidemiology* Prevalence Quality of Life Questionnaires Risk Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcr...
Next Document: Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia.